Overexpression of methyltransferase-like 3 and 14 in oral squamous cell carcinoma.

Abstract

This study aimed to determine expressions of methyltransferase-like 3 (METTL3) and METTL14, two enzymes essential for mRNA methylation at the adenosine (m6 A), in oral squamous cell carcinoma (OSCC) and to investigate in vitro aggressiveness of their aberrant expressions. METTL3 and METTL14 expressions in 50 OSCC and 11 normal oral tissues were examined by immunohistochemistry. METTL3 and METTL14 expressions and m6 A amounts were determined in three OSCC cell lines, including HN5, HN6, and HN15. Cell proliferation, migration, and invasion were studied by BrdU, wound healing, and Transwell chamber assays, after silencing of METTL3, METTL14, or both by siRNA transfection. Immunostaining of METTL3 and METTL14 was localized in cancer cell nuclei. The mean percentages of METTL3- and METTL14-positive cells were significantly increased in OSCC tissues (p<0.001). The percentages of METTL3- and METTL14-positive cells were correlated with the advanced pTNM stages (p<0.05) and with the degrees of histopathological differentiation in OSCC (r=0.564 and r=0.316, respectively; p<0.001). By the COX multivariate analysis, both overexpressed METTL3 and METTL14 were significantly associated with short overall survival (p<0.05). Both METTL3 and METTL14 expressions and the m6 A amounts were significantly increased in HN6 (p<0.05). Silencing of METTL3 and METTL14 in HN6significantly inhibited cell proliferation (p<0.01), but it failed to mitigate cell migration or invasion. METTL3 and METTL14 are overexpressed in OSCC tissues and in the HN6 OSCC cell line that promotes cell proliferation. Overexpressed METTL3 or METTL14 is found to be an independent prognostic factor for short overall survival in patients with OSCC.